GPT-Rosalind (OpenAI) vs Olmo 3 (AI2)
Which one should you pick? Here's the full breakdown.
GPT-Rosalind (OpenAI)
OpenAI's first domain-specific model -- life sciences, drug discovery, translational medicine. Launched 2026-04-16 as a Trusted Access research preview. Launch partners: Amgen, Moderna, Allen Institute, Thermo Fisher. Paired with a Life Sciences Codex plugin (50+ scientific tool integrations)
Olmo 3 (AI2)
Allen Institute for AI's fully-open frontier reasoning models -- Olmo 3 family (2025-11-20) includes 7B and 32B sizes, four variants (Base, Think, Instruct, RLZero). Apache 2.0 with fully open data + checkpoints + training logs. Olmo 3-Think 32B matches Qwen3-32B-Thinking at 6x fewer training tokens
| Category | GPT-Rosalind (OpenAI) | Olmo 3 (AI2) |
|---|---|---|
| Ease of Use | 3.0 | 6.0 |
| Output Quality | 9.0 | 8.0 |
| Value | 7.0 | 9.5 |
| Features | 8.0 | 8.0 |
| Overall | 6.8 | 7.9 |
Pricing Comparison
| Feature | GPT-Rosalind (OpenAI) | Olmo 3 (AI2) |
|---|---|---|
| Free Tier | No | Yes |
| Starting Price | Invite only | $0 |
Which Should You Pick?
Pick GPT-Rosalind (OpenAI) if...
- ✓Higher output quality (9 vs 8)
Researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get Trusted Access. Also relevant to anyone building life-sciences AI products who needs to understand where OpenAI's vertical strategy is heading.
Visit GPT-Rosalind (OpenAI)Pick Olmo 3 (AI2) if...
- ✓Easier to use (6 vs 3)
- ✓Better value for money (9.5/10)
- ✓Has a free tier
AI researchers doing reproducibility work, training-data studies, instruction-tuning research, or RLHF-free (RLZero) experimentation. Also valuable for academic institutions and non-profits that want to use an open-weight model whose provenance is fully auditable. Good as a teaching / learning model where inspecting checkpoints matters.
Visit Olmo 3 (AI2)Our Verdict
Olmo 3 (AI2) is the clear winner here with 7.9/10 vs 6.8/10. GPT-Rosalind (OpenAI) isn't bad, but Olmo 3 (AI2) outperforms it across the board. Pick GPT-Rosalind (OpenAI) only if researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get trusted access.